BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Hong_Kong
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:HKT
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250305T180000
DTEND;TZID=America/Halifax:20250305T190000
DTSTAMP:20260505T112608
CREATED:20250208T111251Z
LAST-MODIFIED:20250608T085957Z
UID:10000131-1741197600-1741201200@oncodaily.com
SUMMARY:People\, places\, and platforms that support a cancer patient’s journey by SPCC
DESCRIPTION:People\, places\, and platforms that support a cancer patient’s journey by SPCC will be held at March 5\, 2025\, Virtually. \nThis conference focuses on the various people\, places\, and platforms that support a cancer patient’s journey. It highlights the importance of a comprehensive support network that goes beyond medical treatment. Compassionate healthcare professionals\, supportive family members\, specialized medical centers\, and digital innovations all play a vital role in providing comfort\, guidance\, and resources. \nThese interconnected elements help empower patients to face their cancer journey with resilience and strength. The session will feature speakers Aleksandra Filipovic\, Steve Bierman\, and Alejandro Piris\, who will share their insights on how these diverse forms of support contribute to improving patient outcomes.
URL:https://oncodaily.com/event/239077
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/Webinar_05_Mar_Banner_Newsletter.jpg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250129T180000
DTEND;TZID=America/Halifax:20250129T210000
DTSTAMP:20260505T112608
CREATED:20250113T170456Z
LAST-MODIFIED:20250608T082151Z
UID:10000117-1738173600-1738184400@oncodaily.com
SUMMARY:Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC
DESCRIPTION:Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC will be held at January 29th\, 2025 at 6 pm. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe Outlook for the HR+/HER2- MBC Treatment Landscape in 2025 and Beyond Live Webinar will focus on the latest advancements and future directions in treating HR+ HER2- metastatic breast cancer (MBC). Experts will review recent clinical trial data\, discuss the current treatment landscape\, and explore the role of novel therapies\, including CDK4/6 inhibitors\, PI3K inhibitors\, and targeted therapies. The evolving landscape will also include next-generation treatments that could reshape patient care in the coming years. \nBiomarker testing plays a central role in guiding treatment decisions for HR+ HER2- MBC\, and the conference will cover how genomic tests and liquid biopsies\, such as ctDNA\, can help personalize therapies. A discussion will also take place on the balance between biomarker-driven therapies versus non-biomarker approaches\, addressing when and how each strategy should be utilized in clinical practice. \nThe conference will also focus on optimizing treatment sequencing based on clinical characteristics such as tumor burden\, mutational status\, and patient performance. Esteemed speakers include Dr. Martin Miguel (Hospital General Universitario Gregorio Marañón\, Spain)\, Dr. Neven Patrick (Universitaire Ziekenhuizen Leuven\, Belgium)\, and Dr. Joyce O’Shaughnessy (Baylor-Sammons Cancer Center\, USA)\, who will share their expertise on the latest research and treatment strategies for HR+ HER2- MBC.
URL:https://oncodaily.com/event/222894
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/WhatsApp-Image-2025-01-12-at-16.20.43.jpeg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Hong_Kong:20250115T140000
DTEND;TZID=Asia/Hong_Kong:20250115T160000
DTSTAMP:20260505T112608
CREATED:20250106T184225Z
LAST-MODIFIED:20250608T082104Z
UID:10000114-1736949600-1736956800@oncodaily.com
SUMMARY:2025 CACA-OncoDaily-SPCC Cancer Summit: Bridging Continents
DESCRIPTION:The Cancer Summit\, organized by the China Anti-Cancer Association (CACA)\, OncoDaily\, Sharing Progress in Cancer Care (SPCC)\, and the World Association for Integrative Oncology (WAIO)\, will take place on January 15\, 2025 via Zoom and will feature simultaneous translation in English and Chinese. \nThe summit will be held at the following times: \n\nChina Standard Time: 02:00-04:00pm\nUS EST: 01:00-03:00am\nCentral European Time: 07:00-09:00am\n\nThe event highlights the crucial rule of collaboration in tackling the current challenges faced in oncology. \nRead more about the event here.
URL:https://oncodaily.com/event/caca-oncodaily-spcc-cancer-summit218610
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/5.1-2025-CACA-Oncodaily-SPCC-Cancer-Summit-Poster.jpg
ORGANIZER;CN="the China Anti-Cancer Association (CACA)":MAILTO:intl@caca.org.cn
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241219T180000
DTEND;TZID=America/Halifax:20241219T190000
DTSTAMP:20260505T112608
CREATED:20241120T054234Z
LAST-MODIFIED:20250608T082053Z
UID:10000072-1734631200-1734634800@oncodaily.com
SUMMARY:Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC
DESCRIPTION:Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC will be held at December 19\, 2024. \nThis live webinar will start with an introduction by Nadia Harbeck from Germany\, setting the stage for the evening’s discussions. Shani Paluch-Shimon from Israel will then present the latest updates on Early Breast Cancer (EBC) from the 2024 San Antonio Breast Cancer Symposium\, covering key advancements and findings. Following this\, Fatima Cardoso from Portugal will provide insights into the updates on Advanced Breast Cancer (ABC) presented at the same symposium\, highlighting new developments and treatments in this area. \nAfter the presentations\, there will be a 20-minute discussion and Q&A session where participants can engage with the speakers and ask questions. The event will conclude with closing remarks from Nadia Harbeck\, summarizing the key points and takeaways from the session. \nFor more information about the 2024 San Antonio Breast Cancer Symposium\, visit here.
URL:https://oncodaily.com/event/188395
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/Webinar_19_Dec_1920x1080.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241218T180000
DTEND;TZID=America/Halifax:20241218T190000
DTSTAMP:20260505T112608
CREATED:20241120T054210Z
LAST-MODIFIED:20250608T082036Z
UID:10000073-1734544800-1734548400@oncodaily.com
SUMMARY:Haemato-oncology highlights from 66th ASH Annual Meeting by SPCC
DESCRIPTION:Haemato-oncology highlights from 66th ASH Annual Meeting by SPCC will be held at December 18\, 2024. \nThis live webinar serves as a crucial platform for oncologists to stay informed about the latest research and breakthroughs in haemato-oncology\, with key highlights from the ASH meeting. By providing insights into recent advancements\, the webinar aims to deepen participants’ understanding\, enhance their education\, and promote best practices in haematology\, ultimately contributing to improved patient care in the field. \nThe webinar will begin with an introduction by Jakob Passweg from Switzerland. David Gomez-Almaguer from Mexico will then present the latest highlights in stem cell transplantation and leukemia. Following that\, Phillip Scheinberg from Brazil will provide key updates on bone marrow failure. After the presentations\, there will be a discussion and Q&A session. The event will conclude with closing remarks by Jakob Passweg. \nFor more information about\, the 66th ASH Annual Meeting visit here. \nSee the Speakers of this event below:\n \nJakob Passweg \n \n David Gomez-Almaguer \n \nPhillip Scheinberg \n  \n  \n 
URL:https://oncodaily.com/event/188403
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/Webinar_18_Dec_Banner_Newsletter.jpg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241217T180000
DTEND;TZID=America/Halifax:20241217T190000
DTSTAMP:20260505T112608
CREATED:20241129T195622Z
LAST-MODIFIED:20250608T082031Z
UID:10000081-1734458400-1734462000@oncodaily.com
SUMMARY:Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024\, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC
DESCRIPTION:Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024\, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC will be held at December 17th\, 2024. \nJoin this Live Webinar on advancements in gastrointestinal (GI) cancer care\, featuring experts Van Cutsem Eric\, Neuzillet Cindy\, and Ruiz-Garcia Erika. The event will explore recent breakthroughs in minimally invasive surgery\, targeted therapies\, and immunotherapy\, which are improving survival rates. The speakers will discuss how molecular insights are driving personalized treatment and transforming patient outcomes. Don’t miss this opportunity to learn about the latest developments and future directions in GI cancer care. \nThe webinar will begin with an introduction by Eric Van Cutsem (BE)\, setting the stage for the discussions on the latest advancements in immuno-oncology for gastrointestinal cancers. Cindy Neuzillet (FR) will then present on the progress of immuno-oncology in biliary and pancreatic cancers\, highlighting the most recent breakthroughs and clinical developments in these challenging and often difficult-to-treat cancers. Following this\, Erika Ruiz Garcia (MX) will focus on the advances in immuno-oncology for colorectal and stomach cancer\, exploring how emerging therapies are improving outcomes for patients with these common malignancies. \nAfter the presentations\, there will be an open discussion and Q&A session\, where attendees can engage directly with the speakers\, ask questions\, and share insights. The webinar will conclude with closing remarks from Eric Van Cutsem (BE)\, summarizing the key points discussed and providing a forward-looking perspective on the future of immuno-oncology in GI cancer care. This session promises to be an informative and interactive opportunity for healthcare professionals and researchers to learn about the latest advancements in this rapidly evolving field. \nLink to register and access the session. \n 
URL:https://oncodaily.com/event/194185
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/Webinar_17_Dec_1920x1080.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241127T180000
DTEND;TZID=America/Halifax:20241127T193000
DTSTAMP:20260505T112608
CREATED:20241120T051946Z
LAST-MODIFIED:20250608T081829Z
UID:10000071-1732730400-1732735800@oncodaily.com
SUMMARY:Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC
DESCRIPTION:Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC will be held at November 27\, 2024. \nIt is a live webinar by SPCC and the event will feature presentations on the latest advancements in breast cancer treatment\, with an introduction by Fiorita Poulakaki from Greece. Michael Gnant from Austria will discuss the de-escalation and escalation of surgery\, radiotherapy\, and adjuvant treatments. Stephen Johnston from the UK will focus on personalizing adjuvant endocrine therapy\, exploring current perspectives and future directions. Following the talks\, there will be a 10-minute discussion and Q&A session\, allowing participants to engage with the speakers. \nThe event will conclude with closing remarks by Fiorita Poulakaki\, summarizing the key takeaways.
URL:https://oncodaily.com/event/188391
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/Webinar_27_Nov_1920x1080.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241105T180000
DTEND;TZID=America/Halifax:20241105T180000
DTSTAMP:20260505T112608
CREATED:20241025T133325Z
LAST-MODIFIED:20250608T081121Z
UID:10000061-1730829600-1730829600@oncodaily.com
SUMMARY:Lung cancer highlights from the ESMO Congress 2024 by SPCC
DESCRIPTION:Lung cancer highlights from the ESMO Congress 2024 by SPCC will take place at November 5th\, 2024. \nIt is a live webinar by SPCC which will be futuring Aleksandra Filipovic\, Alfredo Addeo\, Christian Rolfo. The landscape of treatment for thoracic malignancies has undergone significant and rapid advancements in recent years. New therapies\, including targeted treatments\, immunotherapies\, and innovative surgical techniques\, are now available\, having a profound and positive impact on patients’ lives by improving outcomes and quality of care. However\, with the fast-paced development and the vast amount of clinical data being generated from ongoing research and presented at international conferences\, it can be challenging for clinicians and healthcare professionals to stay up to date with the latest evidence and treatment options. \nFor registration visit here
URL:https://oncodaily.com/event/171740
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Webinar_05_Nov_1920x1080.jpg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
END:VCALENDAR